Antibiotic Profile for Bacteria Isolated from Urinary Tract Infection in Babylon Province

Zainab Hafedh; Safaa A.  Al-Isawi

doi:10.17605/cajmns.v6i4.2828

Zainab Hafedh Directorate of Education in Babylon, Iraq
Safaa A. Al-Isawi Al furat AL-Awsat technical university, Institute Babylon technic, Iraq

DOI: https://doi.org/10.17605/cajmns.v6i4.2828

Keywords: Antibiotic Profile, Bacteria Isolated, Urinary Tract Infection, Babylon, Iraq

Abstract

The purpose of this work was to ascertain the antibiotic profile of bacteria extracted from patient urinary tract infections (UTIs) from community urine samples. Commonly including bacterial and, occasionally, fungal or viral infections, urinary tract infections (UTIs) are healthcare concerns. Antibiotic resistance has grown out of the illogical prescribing and usage of antibiotics in UTI therapy. From male and female patients in several hospitals in Babylon province, Iraq, urine samples (152) were gathered with an age range of 1 to 80 years. In 67% of the samples—99/152—the research noted increase. Of the samples, 78% showed gram-negative bacteria; Gram-positive bacteria were recorded in 22%. Among women, the UTI prevalence was 73%; among men, it was 27%. The most prevalent uropathogenic bacteria were Escherichia coli ( 46%, 46/99), followed by, Staphylococcus aureus ( 25%, 25/99), Enterobacter cloacae ( 9, 9/99), Proteus mirabilis ( 6%, 6/99), Klebsiella pneumoniae (6%, 6/99) , Streptococcus (3%, 3/99) , Acinetobacter ( 2%, 2/99) Pseudomonas aeruginosa ( 1%, 1/99) , and serratia marcescence (1%, 1/99). Pseudomonas aeruginosa , serratia marcescence, Proteus mirabilis, Streptococcus and Acinetobacter as being sensitive to imipenem (100%) and Escherichia coli (93%), sensitive to cefepime(100%) serratia marcescence and Acinetobacter, sensitive to meropenem (100%) serratia marcescence and Streptococcus, sensitive to Amikacin (100%) Acinetobacter and Pseudomonas aeruginosa, sensitive to gentamicin(100%) serratia marcescence, Acinetobacter and Pseudomonas aeruginosa. sensitive to ciprofloxacin(100%) Streptococcus. sensitive to cefotaxime(100%) serratia marcescence . sensitive to levofloxacin(100%) serratia marcescence . and resistant to ceftazidime (100%) serratia marcescence , Acinetobacter , Streptococcus and Pseudomonas aeruginosa. resistant to cefepime (100%) Pseudomonas aeruginosa. resistant to meropenem (100%) Pseudomonas aeruginosa. resistant to Amikacin(100%) serratia marcescence and Streptococcus. resistant to gentamicin(100%) Streptococcus. resistant to ciprofloxacin (100%) serratia marcescence and Pseudomonas aeruginosa. resistant to Ampicillin/sulbactam (100%) serratia marcescence, Klebsiella pneumoniae Streptococcus, and Pseudomonas aeruginosa . resistant to cefotaxime(100%) Pseudomonas aeruginosa and resistant to levofloxacin (100%) Pseudomonas aeruginosa.

References

S. M. Mhana and A. A. Aljanaby, "Bacteriological investigation of pathogenic bacteria causing urinary tract infections: A cross-sectional study," IOP Conf. Ser.: Earth Environ. Sci., vol. 1215, no. 1, p. 012067, 2023.

S. Mekonnen et al., "Bacterial profile, their antibiotic susceptibility pattern, and associated factors of urinary tract infections in children at Hiwot Fana Specialized University Hospital, Eastern Ethiopia," PLOS One, vol. 18, no. 4, p. e0283637, Apr. 2023.

O. Faruk et al., "Microbial isolates from urinary tract infection and their antibiotic resistance pattern in Dhaka city of Bangladesh," J. Knowl. Learn. Sci. Technol., vol. 2, no. 3, pp. 76–87, Dec. 2023.

B. Rahman et al., "Determination of the antibiotic susceptibility pattern of Gram-positive bacteria causing urinary tract infection in Dhaka, Bangladesh," Biomed. Biotechnol. Res. J., vol. 7, no. 3, pp. 432–437, Jul. 2023.

M. Negri et al., "Prevalence and antimicrobial resistance profile of pathogens isolated from patients with urine tract infections admitted to a university hospital in a medium-sized Brazilian city," Rev. Inst. Med. Trop. São Paulo, vol. 66, p. e3, Jan. 2024.

S. Kiiru et al., "Bacterial etiology of urinary tract infections in patients treated at Kenyan health facilities and their resistance towards commonly used antibiotics," PLOS One, vol. 18, no. 5, p. e0277279, May 2023.

M. Harris et al., "Genetic factors that contribute to antibiotic resistance through intrinsic and acquired bacterial genes in urinary tract infections," Microorganisms, vol. 11, no. 6, p. 1407, May 2023.

M. Guliciuc et al., "Exploring the dynamic role of bacterial etiology in complicated urinary tract infections," Medicina, vol. 59, no. 9, p. 1686, Sep. 2023.

C. Mares et al., "Update on urinary tract infection antibiotic resistance—A retrospective study in females in conjunction with clinical data," Life, vol. 14, p. 106, 2024.

Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing, CLSI Document M100-S32, Wayne, PA, 2022.

M. Kibret and B. Abera, "Prevalence and antibiogram of bacterial isolates from urinary tract infections at Dessie Health Research Laboratory, Ethiopia," Asian Pac. J. Trop. Biomed., vol. 4, no. 2, pp. 164–168, 2014.

A. Y. Jameel and D. M. Artoshi, "Prevalence of urinary tract infections and their antimicrobial sensitivity among diabetic and non-diabetic patients in Zakho," Sci. J. Univ. Zakho, vol. 7, no. 4, pp. 125–131, 2019.

B. Arsalan et al., "Pathogen bacteria of the urinary tract isolated from urine cultures and their susceptability," Am. J. Med., vol. 80, no. 2, pp. 208–214, 2014.

M. J. Hossain et al., "Prevalence, antibiotic resistance pattern for bacteriuria from patients with urinary tract infections," Health Sci. Rep., vol. 7, no. 4, p. e2039, 2024.

E. Magliano et al., "Gender and age-dependent etiology of community-acquired urinary tract infections," Sci. World J., vol. 2012, pp. 1–6, 2012.

R. Ikram et al., "An outbreak of multi-drug resistant Escherichia coli urinary tract infection in an elderly population: a case-control study of risk factors," BMC Infect. Dis., vol. 15, p. 224, 2015.

M. A. Belete and M. Saravanan, "A systematic review on drug resistant urinary tract infection among pregnant women in developing countries in Africa and Asia; 2005–2016," Infect. Drug Resist., vol. 13, pp. 1465–1477, 2020.

B. Poojar, "Methodology used in the study," Asian J. Pharm. Clin. Res., vol. 7, pp. 1–5, 2017.

A. Kushwaha, K. Pokharel, and A. R. Kadel, "Antibiotic resistance to Escherichia coli among urine culture-positive patients in a tertiary care hospital in Nepal: a descriptive cross-sectional study," J. Nepal Med. Assoc., vol. 59, pp. 39–45, 2021.

E. O. Omwenga et al., "Urinary tract infection among adults seeking Medicare at Kiambu Level 5 Hospital, Kenya: prevalence, diversity, antimicrobial susceptibility profiles and possible risk factors," unpublished.

D. K. Govindarajan and K. Kandaswamy, "Virulence factors of uropathogens and their role in host pathogen interactions," Cell Surf., vol. 8, p. 100075, 2022.

N. A. J. Al-Tulaibawi, "Prevalence and sensitivity of bacterial urinary tract infection among adult diabetic patients in Misan Province, Iraq," J. Pure Appl. Microbiol., vol. 13, no. 2, pp. 847–853, 2019.

T. Kudinha, "The pathogenesis of Escherichia coli urinary tract infection," in Escherichia coli - Recent Advances on Physiology, Pathogenesis and Biotechnological Applications, A. Samie, Ed. Rijeka, Croatia: Intech, 2017, pp. 45–70.

I. Altamimi et al., "Bacterial pathogens and antimicrobial susceptibility patterns of urinary tract infections in children during COVID-19 2019–2020: A large tertiary care center in Saudi Arabia," Children, vol. 10, p. 97, 2023.

F. M. Mohammed and M. K. Saleh, "Prevalence of bacterial uropathogens in patients with acute, recurrent and chronic urinary tract infection in Kirkuk City, Iraq," Edelweiss Appl. Sci. Technol., vol. 8, no. 6, pp. 624–631, 2024.

M. Karimian et al., "Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: Impact on empirical treatment," J. Glob. Antimicrob. Resist., vol. 9, pp. 3–7, 2017.

H. Kamel and G. Ali, "Determine the prevalence of pathogens and their antibiotics sensitivity for patients suffering from urinary tract infections in Babylon, Iraq," SAR J. Pathol. Microbiol., vol. 5, no. 3, pp. 59–66, 2024.

I. Cock, N. Mavuso, and S. Van Vuuren, "A review of plant-based therapies for the treatment of urinary tract infections in traditional Southern African medicine," Evid.-Based Complement. Altern. Med., vol. 2021, pp. 1–20, 2021.

A. M. Hadi, F. H. Sheri, and A. A. Jaccob, "Urinary tract infection prevalence and antibiotic resistance: A retrospective study in Basra Governorate, Iraq," Al-Mustansiriyah J. Pharm. Sci., vol. 14, no. 2, pp. 129–135, 2014.

N. K. Tektook, K. I. Al-Lehibi, and R. K. Al-Husseinei, "Prevalence of some pathogenic bacteria causing UTI in diabetic patients in Baghdad City, Iraq," Med. J. Babylon, vol. 14, no. 2, pp. 260–266, 2017.

M. M. Vakilzadeh et al., "Antimicrobial resistance among community-acquired uropathogens in Mashhad, Iran," J. Environ. Public Health, vol. 2020, pp. 1–7, 2020.

I. N. Kadariswantiningsih et al., "Antibiotic resistance in Indonesia: A systematic review and meta-analysis of extended-spectrum beta-lactamase-producing bacteria (2008–2024)," Trop. Med. Int. Health, vol. 30, no. 4, pp. 246–259, 2025.

S. Giri et al., "Prevalence and characterization of extended-spectrum β-lactamase-producing antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in ready-to-eat street foods," Antibiotics, vol. 10, no. 7, p. 850, 2021.

A. Mihankhah et al., "Prevalence and antibiotic resistance pattern of bacteria isolated from urinary tract infections in Northern Iran," J. Res. Med. Sci., vol. 22, no. 1, p. 108, 2017.